Authors
Loading...
Chronic activation of CaMKII reduces muscle function in aging, suggesting targeted inhibition may restore strength.
Bene et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: